Search

Your search keyword '"Bregigeon, Sylvie"' showing total 144 results

Search Constraints

Start Over You searched for: Author "Bregigeon, Sylvie" Remove constraint Author: "Bregigeon, Sylvie"
144 results on '"Bregigeon, Sylvie"'

Search Results

2. Efficacy and safety of the novel capsid inhibitor lenacapavir to treat multidrug-resistant HIV: week 52 results of a phase 2/3 trial

4. Efficacy and safety of the novel capsid inhibitor lenacapavir to treat multidrug-resistant HIV: week 52 results of a phase 2/3 trial

7. Striking differences in weight gain after cART initiation depending on early or advanced presentation: results from the ANRS CO4 FHDH cohort

8. Feasibility of Cellular Therapies in HIV Infected Patients: A Monocentric Retrospective Analysis

12. Smoking‐associated morbidities on computed tomography lung cancer screens in HIV‐infected smokers

17. Hepatitis C virus NS3 protease genotyping and drug concentration determination during triple therapy with telaprevir or boceprevir for chronic infection with genotype 1 viruses, southeastern France

19. Kaposi sarcoma among people living with HIV in the French DAT'AIDS cohort between 2010 and 2015

21. Multimorbidity in Elderly Persons According to the Year of Diagnosis of Human Immunodeficiency Virus Infection: A Cross-sectional Dat’AIDS Cohort Study

24. Usefulness of therapeutic drug monitoring of rilpivirine and its relationship with virologic response and resistance in a cohort of naive and pretreated HIV‐infected patients

25. Hepatitis C virus-microelimination program and patient trajectories after hepatitis C virus cure in an outpatient HIV clinical unit

26. Is the Risk of Myocardial Infarction in People With Human Immunodeficiency Virus (HIV) Associated With Atazanavir or Darunavir? A Nested Case-Control Study Within the French Hospital Database on HIV

28. Integrase strand transfer inhibitors and neuropsychiatric adverse events in a large prospective cohort

29. HIV-infected patients’ expectations about emotional and sexual health

30. Concentration–response model of rilpivirine in a cohort of HIV-1-infected naive and pre-treated patients

31. HCV Microelimination Program and Patient Trajectories After HCV Cure in an Outpatient HIV Clinical Unit

32. Patient preferences for characteristics of antiretroviral therapies: results from five European countries

33. Multimorbidity in Elderly Persons According to the Year of Diagnosis of Human Immunodeficiency Virus Infection: A Cross-sectional Dat'AIDS Cohort Study.

34. Is the Risk of Myocardial Infarction in People With Human Immunodeficiency Virus (HIV) Associated With Atazanavir or Darunavir? A Nested Case-Control Study Within the French Hospital Database on HIV.

35. Emergence of uncommon HIV-1 non-B subtypes and circulating recombinant forms and trends in transmission of antiretroviral drug resistance in patients with primary infection during the 2013-2015 period in Marseille, Southeastern France

38. Daclatasvir plasma concentration assessment in HIV–HCV-coinfected real-life patients

39. Emergence of Clusters of CRF02_AG and B Human Immunodeficiency Viral Strains Among Men Having Sex With Men Exhibiting HIV Primary Infection in Southeastern France

40. Factors associated with social deprivation among older persons living with HIV.

47. Impact of Tenofovir dose Adjustment on Both Estimated Glomerular Filtration Rate and Tenofovir trough Concentration

50. Distribution of human papillomavirus genotypes, assessment of HPV 16 and 18 viral load and anal related lesions in HIV positive patients: A cross-sectional analysis.

Catalog

Books, media, physical & digital resources